Free Trial

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 1,693,870 Shares of Privia Health Group, Inc. $PRVA

Privia Health Group logo with Medical background

Key Points

  • UBS Asset Management significantly increased its stake in Privia Health Group by 180.4% during the first quarter, owning approximately 2.16% of the company, valued at $59.1 million.
  • Privia Health reported quarterly earnings with a net margin of 0.78%, achieving revenue of $521.15 million, exceeding expectations despite missing EPS estimates.
  • Wall Street analysts maintain a consensus Moderate Buy rating for Privia Health Group, with a price target of $28.58, highlighting strong growth potential despite recent rating adjustments.
  • MarketBeat previews the top five stocks to own by November 1st.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 180.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 2,633,040 shares of the company's stock after acquiring an additional 1,693,870 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 2.16% of Privia Health Group worth $59,112,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Bessemer Group Inc. lifted its holdings in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in Privia Health Group by 4.6% during the first quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock valued at $1,243,000 after purchasing an additional 2,413 shares during the last quarter. GAMMA Investing LLC boosted its position in Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in Privia Health Group during the first quarter valued at approximately $387,000. Finally, Cerity Partners LLC boosted its position in Privia Health Group by 122.1% during the first quarter. Cerity Partners LLC now owns 25,821 shares of the company's stock valued at $580,000 after purchasing an additional 14,195 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Stephens reissued an "overweight" rating and set a $32.00 price target on shares of Privia Health Group in a research report on Thursday, September 4th. Zacks Research upgraded shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 19th. JPMorgan Chase & Co. raised their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, May 28th. Citigroup reiterated an "outperform" rating on shares of Privia Health Group in a research note on Friday, August 29th. Finally, Piper Sandler cut their target price on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $28.58.

View Our Latest Stock Analysis on Privia Health Group

Privia Health Group Trading Down 1.0%

PRVA stock traded down $0.23 during mid-day trading on Friday, hitting $22.37. 3,224,296 shares of the company were exchanged, compared to its average volume of 670,120. The business has a 50 day simple moving average of $21.24 and a 200-day simple moving average of $22.45. The stock has a market capitalization of $2.75 billion, a PE ratio of 203.38, a price-to-earnings-growth ratio of 3.28 and a beta of 0.82. Privia Health Group, Inc. has a 1-year low of $16.47 and a 1-year high of $26.09.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $521.15 million during the quarter, compared to analyst estimates of $466.97 million. During the same quarter in the previous year, the firm posted $0.19 earnings per share. The firm's quarterly revenue was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. Equities research analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.